Reduced hippocampal glutamate in Alzheimer disease

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

Marquardt, D. W. (1963) · Journal of the Society for Industrial and Applied Mathematics · doi:10.1137/0111030 · Cited by 30,728

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781

Cornell scale for depression in dementia

Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678

Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type

Morris, J. C. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004870 · Cited by 1,641

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592

Multimodal image coregistration and partitioning--a unified framework.

Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 1,051

The Return of the Frequency Sweep: Designing Adiabatic Pulses for Contemporary NMR

Garwood, M., & DelaBarre, L. J. (2001) · Journal of Magnetic Resonance · doi:10.1006/jmre.2001.2340 · Cited by 974

Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells

Brand, A., Richter‐Landsberg, C., & Leibfritz, D. (1994) · Developmental Neuroscience · doi:10.1159/000111347 · Cited by 889

Cognitive-enhancing effects of hydrolysate of polygalasaponin in SAMP8 mice

Xu, P., Xu, S., Wang, K., Lü, C., Zhang, H., Pan, R., Chang, Q., Yang, Y., Li, Y., & Liu, X. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500321 · Cited by 14

Excitotoxicity

Mattson, M. P. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch4 · Cited by 17

Sphingolipids and DHA Improve Cognitive Deficits in Aged Beagle Dogs

Araujo, J. A., Segarra, S., Mendes, J., Paradis, A., Brooks, M., Thevarkunnel, S., & Milgram, N. W. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.646451 · Cited by 13

In-vivoandin-vitrotechniques used to investigate Alzheimer's disease

Tiwari, V., Solanki, V., & Tiwari, M. (2015) · Frontiers in Life Science · doi:10.1080/21553769.2015.1044129 · Cited by 13

Proton MR Spectroscopy in Patients with Nonlesional Insular Cortex Epilepsy Confirmed by Invasive EEG Recordings

Aitouche, Y., Gibbs, S. A., Gilbert, G., Boucher, O., Bouthillier, A., & Nguyen, D. K. (2017) · Journal of Neuroimaging · doi:10.1111/jon.12436 · Cited by 13

Copper chloride dose-dependently alters spatial learning and memory, and glutamate levels, in the hippocampus of rats

Zhang, G., Li, Q., Gao, W., Liu, S., Wu, R., Shen, Z., Liu, W., & Chen, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8278 · Cited by 12

Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer’s Disease

Tian, J., Stucky, C. S., Wang, T., Muma, N. A., Johnson, M. A., & Du, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230072 · Cited by 13

Abnormal levels of brain metabolites may mediate cognitive impairment in stroke-free patients with cerebrovascular risk factors

Sun, D., Zhang, J., Fan, Y., Liu, X., Gao, Y., Wu, G., Yan, Y., & Zeng, J. (2014) · Age and Ageing · doi:10.1093/ageing/afu027 · Cited by 12

Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study

Wang, S., Yuan, J., Guo, X., Peng, P., Gu, H., Niu, S., Fregni, F., Chen, A. C. N., & Hu, W. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000104 · Cited by 12

Photons Induce Vesicular Exocytotic Release of Glutamate in a Power-Dependent Way

Cervetto, C., Amaroli, A., Amato, S., Gatta, E., Diaspro, A., Maura, G., Signore, A., Benedicenti, S., & Marcoli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310977 · Cited by 11

Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy (1H MRS)

Tan, G. M., Beacher, F. D. C. C., Daly, E., Horder, J., Prasher, V., Hanney, M. L., Morris, R. G., Lovestone, S., Murphy, K. C., Simmons, A., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-42 · Cited by 13

Monoterpenes and Diterpenes in Combating Alzheimer Disease, Mechanisms, and Clinical Insights: A Comprehensive Review

Hadipour, E., Shahangian, S. S., & Mashayekhi, F. (2024) · Caspian Journal of Neurological Sciences · doi:10.32598/cjns.10.36.460.1 · Cited by 9

Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer’s Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE Genotype

Kara, F., & Kantarci, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810064 · Cited by 10

Reversed-phase ion-pair high performance liquid chromatography with electrochemical detection for simultaneous quantification of neurotransmitters in mice brain tissues

Jung, Y.-J., Oh, M. S., Eo, H., Kwon, H., & Hong, S.-P. (2024) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2024.2363304 · Cited by 9

Gray matter gamma‐hydroxy‐butyric acid and glutamate reflect beta‐amyloid burden at old age

Schreiner, S. J., Bergen, J. M. G. V., Gietl, A. F., Buck, A., Höck, C., Pruessmann, K. P., Henning, A., & Unschuld, P. G. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12587 · Cited by 8

Altered glutamate–glutamine and amide proton transfer-weighted values in the hippocampus of patients with amnestic mild cognitive impairment: A novel combined imaging diagnostic marker

Chen, X., Gong, T., Chen, T., Xu, C., Li, Y., Song, Q., Lin, L., Oeltzschner, G., Edden, R. A. E., Xia, Z., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1089300 · Cited by 8

Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging

Liu, C. H. (2015) · Future Neurology · doi:10.2217/fnl.14.60 · Cited by 8

Detection of Association Features Based on Gene Eigenvalues and MRI Imaging Using Genetic Weighted Random Forest

Hu, Z., Wang, X., Li, M., Liu, W., Wu, F., & Meng, X. (2022) · Genes · doi:10.3390/genes13122344 · Cited by 7

Magnetic resonance spectroscopy investigation in the right human hippocampus following spinal cord injury

Pfyffer, D., Zimmermann, S., Şimşek, K., Kreis, R., Freund, P., & Seif, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1120227 · Cited by 7

Molecular Defects of Vitamin B6 Metabolism Associated with Neonatal Epileptic Encephalopathy

Mohini, S., di Salvo, M. L., Contestabile, R., Dorothy, N., Karve, S. S., Schirch, V., & Martin, K. (2012) · InTech eBooks · doi:10.5772/29149 · Cited by 7

Brain Biomarkers in Familial Alzheimer’s Disease Mouse Models

Hirshler, Y., Venkatasubramanian, P. N., Apolinario, J., Bonds, J. A., Wyrwicz, A. M., & Lazarov, O. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170269 · Cited by 6

Development of a mimetic system for electrochemical detection of glutamate

ALVES, L. M., de Castro, A. C. H., Oliveira, S. M., Júnior, L. C. O., Goulart, L. R., Bonetti, A. M., Machado, A. E. H., Ueira‐Vieira, C., Madurro, J. M., & Brito‐Madurro, A. G. (2016) · Journal of Solid State Electrochemistry · doi:10.1007/s10008-016-3236-1 · Cited by 6

Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease

Mir, R. H., Masoodi, M. H., Shah, A. J., Mohi-ud-din, R., Sabreen, S., Wani, T. U., Jan, R., Javed, M. N., & Mir, P. A. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220903095837 · Cited by 6

Retrospective analysis of Braak stage– and APOE4 allele–dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly

Chen, A. M., Gajdošík, M., Ahmed, W., Ahn, S., Babb, J. S., Blessing, E., Boutajangout, A., de Leon, M. J., Debure, L., Gaggi, N. L., et al. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120742 · Cited by 5

Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence

Mario, A., Leccisotti, I., Claudia, M. M., Bellomo, A., Panza, F., Tommaso, C., & Madia, L. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118199 · Cited by 6

Brain Total Creatine Differs Between Primary Progressive Aphasia (PPA) Subtypes and Correlates with Disease Severity

Hupfeld, K. E., Zöllner, H. J., Oeltzschner, G., Hyatt, H. W., Herrmann, O., Gallegos, J., Hui, S. C. N., Harris, A. D., Edden, R. A. E., & Tsapkini, K. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.11.006 · Cited by 5

Evaluating the real-world representativeness of participants with mild cognitive impairment in Canadian research protocols: a comparison of the characteristics of a memory clinic patients and research samples

Huang, V., Hogan, D. B., Ismail, Z., Maxwell, C. J., Smith, E. E., & Callahan, B. L. (2020) · Canadian Geriatrics Journal · doi:10.5770/cgj.23.416 · Cited by 5

Sleep disturbance impaired memory consolidation via lateralized disruption of metabolite in the thalamus and hippocampus: A cross-sectional proton magnetic resonance spectroscopy study

Fan, X., Mao, X., Yu, P., Han, D., Chen, C., Wang, H., Zhang, X., Liu, S., Chen, W., Chen, Z., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241295401 · Cited by 5

NMR Metabolomic Profiling of Differentiated SH-SY5Y Neuronal Cells: Amyloid-β Toxicity and Protective Effects of Galantamine and Lycorine

Kola, A., Costanti, F., Kahfi, J., Emwas, A.-H. M., Jaremko, M., & Valensin, D. (2025) · Cells · doi:10.3390/cells14070525 · Cited by 4

Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis

Goyzueta-Mamani, L. D., Chávez‐Fumagalli, M. Á., Alvarez, K. L. F., Aguilar-Pineda, J. A., Nieto-Montesinos, R., Dávila-Del-Carpio, G., Vera-López, K. J., & Cardenas, C. L. L. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220408114129 · Cited by 3

Value of magnetic resonance spectroscopy in geriatric patients with cognitive impairment

Kotb, M. A., Kamal, A. M., Aldossary, N. M., Alsify, A. A., & Ahmed, Y. M. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-0147-y · Cited by 4

Age-related differences in resting glutamate levels and glutamate uptake in the hippocampus and frontal cortex of C57BL/6 mice

Pomerleau, F., Sulkowski, B. A., Suhail, C., Quintero, J. E., Littrell, O. M., Murphy, M. P., Huettl, P. F., & Gerhardt, G. A. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.03.008 · Cited by 3

Magnetic Resonance Spectroscopy in Dementia

Graff‐Radford, J., & Kantarci, K. (2016) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-33555-1_4 · Cited by 3

Differential Effects of Liver Regeneration on Aging‐Related Changes in Gene Expression and Metabolic Function

Murayama, R., Horisawa, K., Miura, S., Taniguchi, S., Shu, J., Takahashi, M., Izumi, Y., Bamba, T., Ishigami, K., & Suzuki, A. (2025) · Aging Cell · doi:10.1111/acel.70197 · Cited by 2

Predifferentiation Neurotoxicity of GenX Exposure on hiPSC-Derived Cortical Neurons

Wu, S., Xie, J., Zhao, X., Zhao, H., Sánchez, O. F., Yu, S., Rochet, J.-C., Freeman, J. L., & Yuan, C. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c13193 · Cited by 2

Association of Alzheimer's Disease with Promoter Variations in NPY2R Gene

Karimzadeh, M. R., Najmadini, A., Azhdari, S., Zatalian, N., Zandi, F., Salmani, N., & Saeidi, K. (2025) · Reports of Biochemistry and Molecular Biology · doi:10.61882/rbmb.13.4.507 · Cited by 2

Huperzine aggravated neurochemical and volumetric changes induced by D-galactose in the model of neurodegeneration in rats

Melicherčík, Ľ., Tvrdík, T., Novakova, K., Nemec, M., Kaliňák, M., Bačiak, L., & Kašparová, S. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105365 · Cited by 2

Imbalance Glutathione Biosynthesis in ASD: A kinetic patterns “in vivo”

Jiménez-Espinoza, C., Marcano, F., & González–Mora, J. L. (2018) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-04-06098 · Cited by 2

Integrating Neuroimaging Measures in Nursing Research

Figuracion, K. C., Thompson, H. J., & Donald, C. L. M. (2022) · Biological Research For Nursing · doi:10.1177/10998004221140608 · Cited by 2

Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

Burhan, A. M., Bartha, R., Bocti, C., BORRIE, M. J., Laforce, R. J., Rosa‐Neto, P., & Soucy, J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alz192 · Cited by 2

Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer’s disease of the Alzheimer’s Disease Neuroimaging Initiative

Gao, Y., Zhang, H., & Hu, Y. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.110828 · Cited by 1

Hippocampal dysmetabolism contributes to cognitive loss in autoimmune encephalitis and focal temporal epilepsy

Taraschenko, O. D., Jayagopal, L. A., Mullane, A., Greenman, K., White, M. L., Ghonim, H., Lee, S., Zabad, R., Jasinski, T., & Uberti, M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1597928 · Cited by 1

Magnetic resonance spectroscopy in hospitalised older people shows age and delirium-specific metabolic changes

Richardson, D., Mahmood, A., Binnie, L. R., Khan, U., Rich, P. M., Davis, D. H. J., Hainsworth, A. H., Howe, F. A., & Isaacs, J. D. (2026) · Age and Ageing · doi:10.1093/ageing/afag013 · Cited by 1

The Glutamate–Glutathione axis in neuropsychiatric disorders and cancer: From shared mechanisms to non-invasive biomarkers

Wang, R., Li, Y., Shi, D., Huang, H., Ren, Z., Ge, Y., Chang, Y., & Yan, G. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104215 · Cited by 2

Altered hypothalamic metabolism in chronic cluster headache patients measured with 1H-MRS at ultra-high magnetic field

Jain, A., Rørnes, A. X., Farestveit, A., Grinde, M. T., Nyman, A. K. G., Sitter, B., Meisingset, T. W., Tronvik, E., & Genovese, G. (2026) · The Journal of Headache and Pain · doi:10.1186/s10194-026-02446-4 · Cited by 1

Avaliação por ressonância magnética do volume e composição metabólica da formação hipocampal em pacientes com esclerose múltipla em estágio inicial e suas correlações com a memória de longo prazo

Junqueira, T. D. F. (2014) · doi:10.11606/t.5.2014.tde-24022015-103627

Isotyping the Human TOMM40 Variable-Length Polymorphism by Gene Amplification and Restriction Digest

Greco, S. J., Hamzelou, A., Johnston, J. M., Richardson, S. L., Smith, M. A., Perry, G. L., Ashford, J. W., & Tezapsidis, N. (2012) · Current Alzheimer Research · doi:10.2174/156720512804142921

The contribution of magnetic resonance spectroscopy as biomarker in Alzheimer’s disease

Modrego, P. J. (2012) · Journal of Biomedical Graphics and Computing · doi:10.5430/jbgc.v3n1p66

Terapia de los Sentidos como Tratamiento de la Agitación en Pacientes con la Enfermedad de Alzheimer

Ordóñez, R., & Joaquín, C. (2013) · USFQ Digital Repository (Universidad San Francisco de Quito)

Establishment and validation of hippocampal LTP for characterization of memory enhancing drugs as potential treatment of Alzheimers disease

Würzburg, J.-M.-U. (2011)

GLUTAMATE DYSREGULATION AND HIPPOCAMPAL DYSFUNCTION IN EPILEPTOGENESIS

Batten, S. R. (2013) · UKnowledge (University of Kentucky)

Clinical Proton MR Spectroscopy in Central Nervous System Disorders.

Öz, G., Alger, J. R., Barker, P. B., Bartha, R., Bizzi, A., Boesch, C. H., Bolan, P. J., Brindle, K. M., Cudalbu, C., Di̇nçer, A., et al. (2014) · Archive ouverte UNIGE (University of Geneva) · doi:10.7892/boris.43877

Clinical Magnetic Resonance Neuroimaging in Mild Cognitive Impairment and Alzheimer Disease

Fayed, N. M., García‐Campayo, J., & Viguera, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17103-6_28

Imaging Approaches to Cerebral Cortex Pathology

Bartha, R., & Lee, T.-Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00003-3

An investigation into the importance of T2 relaxation and echo time choice for accurate metabolite biomarker quantification

Carlin, D. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)

Desenvolvimento de biossensor eletroquímico para detecção de glutamato

Alves, L. (2014) · doi:10.14393/ufu.di.2014.371

Magnetic Resonance Spectroscopy

McGavin, L., & Mannava, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-48419-4_17

Research Contributions of Magnetic Resonance Spectroscopy in Psychopathology

Fayed, N. M., Torres, C., Morales, H., Rios, L. F. A., & Fayed, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_45

Etude multimodale de la maladie d'Alzheimer : forme sporadique prodromale, formes génétiques, et altération du traitement visuel

Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)

Research Progress of Hydrogen Proton Magnetic Resonance Spectroscopy in Different Brain Diseases

张, 瑞. (2018) · Advances in Clinical Medicine · doi:10.12677/acm.2018.89144

Magnetic resonance spectroscopy investigation in the human hippocampus following spinal cord injuryPreprint

Pfyffer, D., Zimmermann, S., Şimşek, K., Kreis, R., Freund, P., & Seif, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2337663/v1

Molecular Biomarkers: Overview, Technologies and Strategies

Verma, M., Barh, D., & Azevedo, V. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781782628217-00440

A Comprehensive Study on Relation Between Hodgkin-Huxley Model and Brain-Disorder Disease

Gupta, S., Kumar, K., & Singh, J. (2023) · Soft Computing Research Society eBooks · doi:10.52458/978-81-955020-5-9-99

Chemical Exchange Saturation Transfer (CEST) Imaging

Paech, D., & Loi, L. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_11 · Cited by 1

What Is Neurodegeneration?

Zeydan, B., & Kantarci, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_1 · Cited by 2

Miniaturized Electrochemical Sensing Platforms for Quantitative Monitoring of Glutamate Dynamics in the Central Nervous System

Wang, Q., Yang, C., Chen, S., & Li, J. (2024) · Angewandte Chemie · doi:10.1002/ange.202406867

Age-Related Changes in Resting Glutamate Levels and Glutamate Uptake in the Hippocampus and Frontal Cortex of C57bl/6 MicePreprint

Pomerleau, F., Sulkowski, B. A., Suhail, C., Quintero, J. E., Littrell, O. M., Murphy, M. P., Huettl, P. F., & Gerhardt, G. A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5067082

Unveiling paths to Alzheimer’s disease: excitation-inhibition ratio shapes hierarchical dynamicsPreprint

Saviola, F., Ferrari, A., Corbo, D., Pievani, M., Saglia, S., Cattaneo, A., D’Aprile, I., Quattrini, G., Cantoni, V., Premi, E., et al. (2025) · medRxiv · doi:10.1101/2025.02.25.25322663

Application of Proton MRS in the Alzheimer’s Disease Continuum: Recent Advances and Future Directions

Kara, F., & Kantarci, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_9

Gestational sevoflurane exposure induces amino acid metabolic reprogramming and cognitive deficits in offspring

Ma, J., Xu, L., Sun, N. C., Song, J., Wang, J., Wang, J., Li, L., Chu, Q., Wang, L.-J., & Song, Q. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124246

Longitudinal 7T MRS Study of Glutamate and GABA Dynamics in Alzheimer’s Disease Progression: From hyper- to hypoexcitationPreprint

Göschel, L., Dell’Orco, A., Aydın, S., Teunissen, C. E., Hoede, P. L., Melin, J., Pendrill, L., Roemer, S. N., Franzmeier, N., Flöel, A., et al. (2026) · medRxiv · doi:10.64898/2026.02.04.26345353

Age-dependent alterations of TRPA1 and urocortin 1 signaling in the Edinger–Westphal nucleus in a mouse model of Alzheimer’s disease

Prókay, A. P., Konkoly, J., Kormos, V., Biró-Sütő, T., Kriszta, G., Szentmártoni, H. P., Berta, G., Gaszner, B., Zelena, D., & Pintér, E. (2026) · Scientific Reports · doi:10.1038/s41598-026-44022-5

Étude des bases cérébrales de la maladie à corps de Lewy par IRM multimodale

Chabran, E. (2019) · theses.fr (ABES) · doi:10.70675/0e043513z1fabz4531za279z1f82876b9864

Novel salivary biomarkers of Alzheimer's disease identified by integrated metabolomics and microbiomics analysis

Chen, H., Chen, H., Xie, L., Jiang, K., Xia, E., Mao, J., Liu, Z., Li, X., Xiao, Y., Qian, X., et al. (2026) · Clinical Oral Investigations · doi:10.1007/s00784-026-06933-5

In vivo evidence for soluble Aβ oligomer-driven neuronal metabolic dysfunction in 5xFAD mice

Dashora, C., & Patel, A. B. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02130-4

An intestine-centric view of neurodegeneration: How intestine-derived signals mediate the intestine-brain axis to impact Alzheimer's disease

Shen, S., Zhou, Y., Qian, J., Li, T., Hu, X., Ji, X., Zhang, X., & Zhou, D. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579102

Singlet-filtered 1 H-MRS at 3 T yields phantom-calibrated apparent regional glutamate values in healthy adults and compartmental glutamate alterations in glioma: a prospective observational studyPreprint

Wang, J., Yang, C., Wang, W., Feng, R., Yang, Y., Yao, Y., Xin, J., Rominger, A., Li, Y., Ni, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10871783/v1

Study of ~1H MR Spectroscopy in Hippocampus Metabolites of Alzheimer Disease

Jianpin, Q. (2009) · Radiologic Practice

Brain Glutamate Levels Are Decreased in Alzheimer’s Disease: A Magnetic Resonance Spectroscopy Study

Fayed, N., Modrego, P. J., Rojas-Salinas, G., & Aguilar, K. (2011) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317511421780 · Cited by 128

Metabolic Changes in Patients with Alzheimer's Disease Assessed by High Field Proton Magnetic Resonance Spectroscopy

Feng, X. (2010) · Chinese Computed Medical Imaging

Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and alzheimer disease

Wang, Z., Zhao, C., Lei, Y., Zhou, W., & Li, K. (2009) · Acta Radiologica · doi:10.1080/02841850802709219 · Cited by 64

P2–349: Analysis of metabolite levels and ratios in age matched controls, mild cognitive impairment, and Alzheimer's disease converters using 1H magnetic resonance spectroscopy

Mueller, C., Bartnik‐Olson, B., Patra, S., Baqai, W. K., Petersen, F. F., Holshouser, B. A., & Kirsch, W. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1189